These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

EZH1 is a key regulator of circadian rhythms, stabilizing gene transcription and modifying chromatin to maintain genetic ...

A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...